{"url_path":"/sec/lly/8-k/2026-05-20/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-20","source_url":"https://www.sec.gov/Archives/edgar/data/59478/0001193125-26-232707-index.html","accession_number":"0001193125-26-232707","cik":"0000059478","ticker":"LLY","issuer_name":"ELI LILLY & Co","edgar_url":"https://www.sec.gov/Archives/edgar/data/59478/0001193125-26-232707-index.html","primary_entity_key":"0000059478","primary_entity_name":"ELI LILLY & Co"},"word_count":395,"has_tables":true,"body_markdown":"Item 9.01\n\nFinancial Statements and Exhibits.\n\n(d) Exhibits\n\n \n\n 1.1\n  \n[Underwriting Agreement, dated May 6, 2026, among Eli Lilly and Company and Morgan Stanley & Co. LLC, Citigroup Global Markets Inc., Deutsche Bank Securities Inc. and Goldman Sachs & Co. LLC, as representatives of the several underwriters named therein.](d148580dex11.htm)\n\n 4.1*\n  \n[Indenture, dated February 1, 1991, among Eli Lilly and Company and Deutsche Bank Trust Company Americas, as successor to Citibank, N.A., as Trustee.](http://www.sec.gov/Archives/edgar/data/59478/000005947813000010/exhibit41-indenturedatedfe.htm)\n\n 4.2±\n  \n[Tripartite Agreement, dated September 13, 2007, appointing Deutsche Bank Trust Company Americas as Successor Trustee under the Indenture listed above.](http://www.sec.gov/Archives/edgar/data/59478/000095015209001897/c49534exv4w2.htm)\n\n 4.3\n  \n[Form of Officers’ Certificate setting forth the terms and form of the Fixed Rate Notes.](d148580dex43.htm)\n\n 4.4\n  \n[Form of Officers’ Certificate setting forth the terms and form of the Floating Rate Notes.](d148580dex44.htm)\n\n 4.5\n  \n[Form of Floating Rate Note due 2028 (included in Exhibit 4.4 above).](d148580dex44.htm)\n\n 4.6\n  \n[Form of Floating Rate Note due 2029 (included in Exhibit 4.4 above).](d148580dex44.htm)\n\n 4.7\n  \n[Form of 4.150% Note due 2029 (included in Exhibit 4.3 above).](d148580dex43.htm)\n\n 4.8\n  \n[Form of 4.375% Note due 2031 (included in Exhibit 4.3 above).](d148580dex43.htm)\n\n 4.9\n  \n[Form of 4.650% Note due 2033 (included in Exhibit 4.3 above).](d148580dex43.htm)\n\n4.10\n  \n[Form of 4.850% Note due 2036 (included in Exhibit 4.3 above).](d148580dex43.htm)\n\n4.11\n  \n[Form of 5.600% Note due 2056 (included in Exhibit 4.3 above).](d148580dex43.htm)\n\n4.12\n  \n[Form of 5.700% Note due 2066 (included in Exhibit 4.3 above).](d148580dex43.htm)\n\n 5.1\n  \n[Opinion of Kirkland & Ellis LLP.](d148580dex51.htm)\n\n 5.2\n  \n[Opinion of Jamie Burnett, Esq.](d148580dex52.htm)\n\n23.1\n  \n[Consent of Kirkland & Ellis LLP (included as part of Exhibit 5.1).](d148580dex51.htm)\n\n23.2\n  \n[Consent of Jamie Burnett, Esq. (included as part of Exhibit 5.2).](d148580dex52.htm)\n\n104\n  \nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\n \n\n*\n\nIncorporated by reference to the same-numbered exhibit of the Company’s Registration Statement on Form S-3 (File No. 333-186979), filed with the Securities and Exchange Commission (“SEC”) on March 1, 2013.\n\n±\n\nIncorporated by reference to the same-numbered exhibit of the Company’s Annual Report on Form 10-K for the year ended December 31, 2008 (File No. 001-06351), filed with the SEC on February 27, 2009.\n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\n \n\nELI LILLY AND COMPANY\n\n(Registrant)\n\nBy:\n \n\n/s/ Jon Haug\n\nName:\n \nJon Haug\n\nTitle:\n \nSenior Vice President, Treasurer and Corporate Finance and Investment Banking\n\nDated:\n \nMay 20, 2026"}